Table of Contents
Pathology Research International
Volume 2012, Article ID 235418, 12 pages
http://dx.doi.org/10.1155/2012/235418
Clinical Study

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer

1Laboratory of Recognition and Biological Activity Assays, Department of Quality Control, Center of Molecular Immunology, Playa, P.O. Box 16040, Havana 11600, Cuba
2Department of Pathology, Manuel Fajardo General Hospital, Plaza de la Revolución, Havana 10400, Cuba
3Research and Development Direction, Center of Molecular Immunology, Havana, Cuba

Received 11 October 2011; Accepted 20 November 2011

Academic Editor: Bertha Garcia

Copyright © 2012 Rancés Blanco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rancés Blanco, Charles E. Rengifo, Mercedes Cedeño, Milagros Frómeta, Enrique Rengifo, and Adriana Carr, “Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer,” Pathology Research International, vol. 2012, Article ID 235418, 12 pages, 2012. https://doi.org/10.1155/2012/235418.